These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6745090)

  • 1. No effect of smoking on sulfamethazine acetylation.
    Miller ME; Cosgriff JM
    Drug Intell Clin Pharm; 1984; 18(7-8):620-2. PubMed ID: 6745090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphic acetylation of the antibacterials, sulfamethazine and dapsone, in South Indian subjects.
    Peters JH; Gordon GR; Karat AB
    Am J Trop Med Hyg; 1975 Jul; 24(4):641-8. PubMed ID: 1155699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of nonlinear disposition kinetics of sulfamethazine.
    du Souich P; Lalka D; Slaughter R; Elvin AT; McLean AJ
    Clin Pharmacol Ther; 1979 Feb; 25(2):172-83. PubMed ID: 759070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between the metabolism of procainamide and sulfamethazine.
    Giardina E-GV ; Stein RM; Bigger JT
    Circulation; 1977 Feb; 55(2):388-94. PubMed ID: 832354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening methods using sulfamethazine for determining acetylator phenotype.
    du Souich P; McLean AJ; Stoeckel K; Ohlendorf D; Gibaldi M
    Clin Pharmacol Ther; 1979 Dec; 26(6):757-65. PubMed ID: 498718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine.
    Zysset T; Peretti E
    Eur J Clin Pharmacol; 1986; 30(4):463-6. PubMed ID: 3743623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acetaminophen on sulfamethazine acetylation in male volunteers.
    Tahir IM; Iqbal T; Saleem S; Mehboob H; Akhter N; Riaz M
    Int J Immunopathol Pharmacol; 2016 Mar; 29(1):17-22. PubMed ID: 26519524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylation phenotype in hypertensive patients.
    Huang CY; Chu JY; Yen TC
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Jan; 8(1):1-5. PubMed ID: 1548734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical screening procedures for sulfamethazine and N4-acetylsulfamethazine in milk at low parts-per-billion levels.
    Schwartz DP; Lightfield AR
    J AOAC Int; 1995; 78(4):967-70. PubMed ID: 7580337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylation phenotyping with sulphadimidine in a Turkish population.
    Bozkurt A; Basci NE; Kalan S; Tuncer M; Kayaalp SO
    Eur J Clin Pharmacol; 1990; 38(1):53-6. PubMed ID: 2328748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of sulfamethazine acetylation by hydrocortisone in the rabbit.
    Reeves PT; Minchin RF; Ilett KF
    Drug Metab Dispos; 1988; 16(1):110-5. PubMed ID: 2894938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive binding of sulfamethazine and its N-acetylated metabolite.
    Tsang YC; Thiessen JJ
    Biopharm Drug Dispos; 1989; 10(5):465-79. PubMed ID: 2804251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.
    Hein DW; Doll MA
    Arch Toxicol; 2017 Aug; 91(8):2827-2835. PubMed ID: 28523442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and dosage dependency in the plasma disposition and the renal clearance of sulfamethazine and its N4-acetyl and hydroxy metabolites in calves and cows.
    Nouws JF; Vree TB; Baakman M; Driessens F; Breukink HJ; Mevius D
    Am J Vet Res; 1986 Mar; 47(3):642-9. PubMed ID: 3963566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic discrimination of three sulfamethazine acetylation phenotypes.
    Chapron DJ; Kramer PA; Mercik SA
    Clin Pharmacol Ther; 1980 Jan; 27(1):104-13. PubMed ID: 7351110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylation phenotyping with sulfamethazine in an Iranian population.
    Sardaş S; Lahijany B; Cok I; Karakaya AE
    Pharmacogenetics; 1993 Jun; 3(3):131-4. PubMed ID: 8334437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-acetylation of sulfamethazine and p-aminobenzoic acid by human liver slices in dynamic organ culture.
    Gunawardhana L; Barr J; Weir AJ; Brendel K; Sipes IG
    Drug Metab Dispos; 1991; 19(3):648-54. PubMed ID: 1680632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylator polymorphism in Parkinson's disease.
    Ladero JM; Jimenez FJ; Benitez J; Fernandez-Gundin MJ; Martinez C; Llerena A; Cobaleda J; Muñoz JJ
    Eur J Clin Pharmacol; 1989; 37(4):391-3. PubMed ID: 2598972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of sulfamethazine disposition kinetics to acetylator phenotype in man. A preliminary study.
    Chapron CJ; Blum MR
    J Clin Pharmacol; 1976 Jul; 16(7):338-44. PubMed ID: 947966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible optimization of sulphadimidine dosage for acetylator phenotyping.
    Hombhanje F
    Jpn J Pharmacol; 1991 Aug; 56(4):531-4. PubMed ID: 1744992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.